Hidden malignancy in large polycystic liver and kidney

Clin Exp Nephrol. 2023 May;27(5):490-492. doi: 10.1007/s10157-023-02326-0. Epub 2023 Feb 8.

Hiroki Ito^{1

2}, Takuo Hirose^{3

4}, Takefumi Mori³

¹ Division of Nephrology and Endocrinology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, 1-15-1, Fukumuro, Miyagino, Sendai, 983-8536, Japan. hito@tohoku-mpu.ac.jp.
² Department of Endocrinology and Applied Medical Science, Tohoku University Graduate School of Medicine, 2-1, Seiryo, Aoba, Sendai, 980-8575, Japan. hito@tohoku-mpu.ac.jp.
³ Division of Nephrology and Endocrinology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, 1-15-1, Fukumuro, Miyagino, Sendai, 983-8536, Japan.
⁴ Department of Endocrinology and Applied Medical Science, Tohoku University Graduate School of Medicine, 2-1, Seiryo, Aoba, Sendai, 980-8575, Japan.

No abstract available

Keywords: ADPKD; Malignancy; Pancreatic cancer.

MeSH terms